• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在终末期肝病模型(MELD)系统下同行评审的肝脏分配中的区域差异。

Regional variations in peer reviewed liver allocation under the MELD system.

作者信息

Rodriguez-Luna Hector, Vargas Hugo E, Moss Adyr, Reddy Kunam S, Freeman Richard B, Mulligan David

机构信息

Transplantation Medicine, Mayo Clinic Hospital, Phoenix, Arizona, USA.

出版信息

Am J Transplant. 2005 Sep;5(9):2244-7. doi: 10.1111/j.1600-6143.2005.01008.x.

DOI:10.1111/j.1600-6143.2005.01008.x
PMID:16095504
Abstract

The Model for End-Stage Liver Disease (MELD) is used to assign priority for liver transplantation candidates. The Organ Procurement and Transplantation Network (OPTN) approved recognized exceptional diagnoses (RED's) for which MELD fails to accurately measure priority. Centers can request increased MELD points in cases not recognized by this policy (non-RED's). Our aim was to compare regional practices to justify non-RED requests for MELD adjustments. The UNOS/OPTN database was queried to extract all adult cases for which a non-RED MELD adjustment was requested from 2/27/02 until 8/27/03. The data were stratified by region and justification. Data for 29,510 listings were available. 26,947 had complete diagnosis information. There were 827 non-RED requests of which 477 (57.7%) petitions were approved by the regional review boards (RRBs). The approval rate varied significantly among regions (range: 28-75%, p<0.0001). The most common non-RED's were complications of portal hypertension (48%). The percentage of patients listed with non-RED's varied significantly among regions (0.7-8.3 %, p<0.0001), as did the proportion of patients transplanted with non-RED's (2.1-31.9%, p<0.0001). Demographics did not differ among regions requesting non-REDs.Widespread regional variations exist in the handling of requests for non-REDs. These variations point to the need for reform to standard exception criteria.

摘要

终末期肝病模型(MELD)用于确定肝移植候选者的优先级。器官获取与移植网络(OPTN)批准了一些公认的特殊诊断(RED),对于这些情况MELD无法准确衡量优先级。在该政策未认可的病例(非RED)中,各中心可申请增加MELD分数。我们的目的是比较不同地区的做法,以证明对非RED申请调整MELD的合理性。查询了UNOS/OPTN数据库,以提取2002年2月27日至2003年8月27日期间所有申请非RED的MELD调整的成人病例。数据按地区和理由进行分层。有29510条登记数据可用。26947条有完整的诊断信息。有827项非RED申请,其中477项(57.7%)申请获得地区评审委员会(RRB)批准。各地区的批准率差异显著(范围:28%-75%,p<0.0001)。最常见的非RED是门静脉高压并发症(48%)。各地区列出的非RED患者百分比差异显著(0.7%-8.3%,p<0.0001),接受非RED移植的患者比例也如此(2.1%-31.9%,p<0.0001)。申请非RED的地区之间人口统计学特征无差异。在处理非RED申请方面存在广泛的地区差异。这些差异表明需要改革标准例外标准。

相似文献

1
Regional variations in peer reviewed liver allocation under the MELD system.在终末期肝病模型(MELD)系统下同行评审的肝脏分配中的区域差异。
Am J Transplant. 2005 Sep;5(9):2244-7. doi: 10.1111/j.1600-6143.2005.01008.x.
2
Center variation in the use of nonstandardized model for end-stage liver disease exception points.中心变异在非标准化模型终末期肝病例外点的使用中。
Liver Transpl. 2013 Dec;19(12):1330-42. doi: 10.1002/lt.23732. Epub 2013 Oct 10.
3
Liver transplantation for hepatocellular carcinoma: the MELD impact.肝细胞癌的肝移植:终末期肝病模型(MELD)的影响
Liver Transpl. 2004 Jan;10(1):36-41. doi: 10.1002/lt.20012.
4
Exception point applications for 15 points: an unintended consequence of the share 15 policy.例外点申请 15 分:分享 15 政策的意外后果。
Liver Transpl. 2012 Nov;18(11):1302-9. doi: 10.1002/lt.23537. Epub 2012 Oct 10.
5
The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.先救治病情最重的患者?基于终末期肝病模型的器官分配存在的差异:一个地区的经验。
Liver Transpl. 2003 Nov;9(11):1211-5. doi: 10.1053/jlts.2003.50192.
6
United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.器官共享联合网络中终末期肝病/小儿终末期肝病非标准模型的上诉驳回率的地区差异:对全国审查委员会的支持
Clin Transplant. 2015 Jun;29(6):513-22. doi: 10.1111/ctr.12544. Epub 2015 Apr 16.
7
OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation?器官获取与移植网络(OPTN)关于肝肺综合征患者优先排序的政策:它能提供公平的器官分配吗?
Am J Transplant. 2008 May;8(5):954-64. doi: 10.1111/j.1600-6143.2007.02124.x.
8
Model for end-stage liver disease exceptions committee activity in Argentina: does it provide justice and equity among adult patients waiting for a liver transplant?阿根廷终末期肝病模型例外委员会活动:它是否为等待肝移植的成年患者提供了公正和平等?
HPB (Oxford). 2010 Oct;12(8):531-7. doi: 10.1111/j.1477-2574.2010.00200.x.
9
Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.高 MELD 评分和严重肝性脑病的肝移植候选者的候补名单结局。
Dig Dis Sci. 2018 Jun;63(6):1647-1653. doi: 10.1007/s10620-018-5032-5. Epub 2018 Apr 2.
10
The economic impact of MELD on liver transplant centers.终末期肝病模型(MELD)对肝移植中心的经济影响。
Am J Transplant. 2005 Sep;5(9):2297-301. doi: 10.1111/j.1600-6143.2005.01025.x.

引用本文的文献

1
Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.评估模型在预测经颈静脉肝内门体分流术放置后生存情况的表现。
PLoS One. 2019 May 23;14(5):e0217442. doi: 10.1371/journal.pone.0217442. eCollection 2019.
2
Orthotopic liver transplantation for giant liver haemangioma: A case report.巨大肝血管瘤原位肝移植:一例报告
World J Transplant. 2015 Dec 24;5(4):354-9. doi: 10.5500/wjt.v5.i4.354.
3
Model for End-Stage Liver Disease and liver cirrhosis-related complications.
终末期肝病模型及肝硬化相关并发症
Hepatol Int. 2013 Jun;7(2):347-55. doi: 10.1007/s12072-012-9403-2. Epub 2012 Oct 10.
4
United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.器官共享联合网络中终末期肝病/小儿终末期肝病非标准模型的上诉驳回率的地区差异:对全国审查委员会的支持
Clin Transplant. 2015 Jun;29(6):513-22. doi: 10.1111/ctr.12544. Epub 2015 Apr 16.
5
Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis.原发性硬化性胆管炎和细菌性胆管炎患者的例外点缺乏标准化。
Am J Transplant. 2012 Jun;12(6):1603-9. doi: 10.1111/j.1600-6143.2011.03969.x. Epub 2012 Feb 15.
6
MELD Exceptions and Rates of Waiting List Outcomes.MELD 例外和候补名单结果的比例。
Am J Transplant. 2011 Nov;11(11):2362-71. doi: 10.1111/j.1600-6143.2011.03735.x. Epub 2011 Sep 15.
7
Variation in organ quality between liver transplant centers.不同肝移植中心间的器官质量差异。
Am J Transplant. 2011 May;11(5):958-64. doi: 10.1111/j.1600-6143.2011.03487.x. Epub 2011 Apr 5.
8
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.中等量腹水可识别出等待肝移植的低终末期肝病模型评分患者,此类患者具有较高的死亡风险。
Liver Transpl. 2011 Feb;17(2):129-36. doi: 10.1002/lt.22218.